Attached files
| file | filename |
|---|---|
| S-1 - S-1 - Vericel Corp | a14-18419_1s1.htm |
| EX-23.1 - EX-23.1 - Vericel Corp | a14-18419_1ex23d1.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of Aastrom Biosciences, Inc. of our report dated May 29, 2014 relating to the Special Purpose Combined Financial Statements of the Cell Therapy and Regenerative Medicine Business (the "CTRM business"), a product portfolio of Sanofi, which appears in Aastrom Biosciences, Inc.’s Current Report on Form 8-K/A dated June 16, 2014. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Florham Park, New Jersey
August 5, 2014